These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 14258844)

  • 1. MEASLES VACCINATION. IV. RESPONSES TO TWO DIFFERENT TYPES OF PREPARATIONS GIVEN AS A FOURTH DOSE OF VACCINE.
    NORRBY E; LAGERCRANTZ R; GARD S
    Br Med J; 1965 Mar; 1(5438):813-7. PubMed ID: 14258844
    [No Abstract]   [Full Text] [Related]  

  • 2. MEASLES VACCINATION. II. ANTIBODY TITERS 8 TO 9 MONTHS AFTER VACCINATION WITH AN INACTIVATED VACCINE.
    NORRBY E; CARLSTROEM G; LAGERCRANTZ R; GARD S
    Acta Paediatr (Stockh); 1964 Nov; 53():533-40. PubMed ID: 14225879
    [No Abstract]   [Full Text] [Related]  

  • 3. [VIROLOGICAL AND CLINICAL OBSERVATIONS FOLLOWING ACTIVE MEASLES IMMUNIZATION].
    HAAS R; VIVELL O; GAEDECKE R; SIGNER E; SCHUMACHER H; BERTHOLD H
    Dtsch Med Wochenschr; 1965 Jan; 90():193-200. PubMed ID: 14240834
    [No Abstract]   [Full Text] [Related]  

  • 4. MEASLES VACCINATION. I. SEROLOGIC RESPONSES TO AN INACTIVATED VACCINE.
    NORRBY E; LAGERCRANTZ R; GARD S; CARLSTROEM G
    Arch Gesamte Virusforsch; 1963 Aug; 13():548-58. PubMed ID: 14085248
    [No Abstract]   [Full Text] [Related]  

  • 5. OBSERVATIONS ON THE FURTHER ATTENUATION OF MEASLES VIRUS AND ON LIVE VACCINES PREPARED FROM HIGHLY ATTENUATED LINES OF VIRUS.
    CHU CM; KU YF; CHANG YH
    Chin Med J; 1964 Aug; 83():483-96. PubMed ID: 14174535
    [No Abstract]   [Full Text] [Related]  

  • 6. IMMUNIZATION WITH INACTIVATED MEASLES VIRUS VACCINE.
    GARD S; CARLSTROEM G; LAGERCRANTZ R; NORRBY E
    Arch Gesamte Virusforsch; 1965; 16():315-23. PubMed ID: 14322885
    [No Abstract]   [Full Text] [Related]  

  • 7. RESPONSE OF VOLTA CHILDREN TO JET INOCULATION OF COMBINED LIVE MEASLES, SMALLPOX AND YELLOW FEVER VACCINES.
    MEYER HM; HOSTETLER DD; BERNHEIN BC; ROGERS NG; LAMBIN P; CHASSARY A; LABUSQUIERE R; SMADEL JE
    Bull World Health Organ; 1964; 30(6):783-94. PubMed ID: 14215185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KILLED MEASLES VACCINE PRIOR TO SEVEN MONTHS OF AGE FOLLOWED BY ATTENUATED LIVE VIRUS VACCINE AT NINE MONTHS.
    KARELITZ S; SCHLUEDERBERG A; KANCHANAVATEE P; ARAI M; ACS H
    Arch Gesamte Virusforsch; 1965; 16():343-6. PubMed ID: 14322891
    [No Abstract]   [Full Text] [Related]  

  • 9. COMPARISON OF THE HEMAGGLUTINATION INHIBITION TEST FOR MEASLES WITH SEROLOGICAL TESTS AND ITS APPLICATION TO A FIELD TRIAL.
    KUNITA N; KITAWAKI T; FUNAHASHI S; TOYOSHIMA K
    Biken J; 1963 Jul; 6():45-56. PubMed ID: 14147705
    [No Abstract]   [Full Text] [Related]  

  • 10. STUDIES ON IMMUNITY TO MEASLES.
    KRUGMAN S; GILES JP; FRIEDMAN H; STONE S
    J Pediatr; 1965 Mar; 66():471-88. PubMed ID: 14264306
    [No Abstract]   [Full Text] [Related]  

  • 11. CLINICAL AND SEROLOGICAL OBSERVATIONS ON THE CHILDREN GIVEN ATTENUATED MEASLES VACCINE.
    ARAI M; NAKAMURA M; AKAMATSU T; KIMURA M; KITAYAMA T; KOIDE G
    Acta Paediatr Jpn; 1963 Dec; 14():9-16. PubMed ID: 14200614
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of the immunogenic activity of 2 variants of the measles virus].
    Chiarini A; Brancato P; Sinatra A
    Riv Ist Sieroter Ital; 1968; 43(4):175-88. PubMed ID: 5747129
    [No Abstract]   [Full Text] [Related]  

  • 13. Measles vaccination. 3. Serologic responses to immunization with purified hemagglutinin.
    Norrby E; Lagercrantz R; Gard S; Carlström G
    Acta Paediatr Scand; 1965 Nov; 54(6):581-6. PubMed ID: 5832151
    [No Abstract]   [Full Text] [Related]  

  • 14. SIMULTANEOUS ADMINISTRATION OF ORAL POLIO VACCINE AND GLOBULIN-MODIFIED ATTENUATED MEASLES-VIRUS VACCINE.
    FROESCHLE JE; CASEY H
    J Pediatr; 1965 Jun; 66():1031-4. PubMed ID: 14288455
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
    Boué A; Celers J
    Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
    [No Abstract]   [Full Text] [Related]  

  • 16. SEPARATION OF MEASLES VIRUS COMPONENTS BY EQUILIBRIUM CENTRIFUGATION IN CSCL GRADIENTS. I. CRUDE AND TWEEN AND ETHER TREATED CONCENTRATED TISSUE CULTURE MATERIAL.
    NORRBY E
    Arch Gesamte Virusforsch; 1964; 14():306-18. PubMed ID: 14181216
    [No Abstract]   [Full Text] [Related]  

  • 17. VACCINATION AGAINST MEASLES.
    ENDERS JF
    Aust J Exp Biol Med Sci; 1963 Aug; 41():SUPPL467-89. PubMed ID: 14058869
    [No Abstract]   [Full Text] [Related]  

  • 18. MEASLES VACCINATION IN INFANTS. USE OF KILLED-LIVE COMBINATIONS.
    ALEXANDER ER; BANSMER CM; HARRIS ES; GILES B; SPARKS MJ
    Am J Dis Child; 1964 Nov; 108():470-8. PubMed ID: 14208407
    [No Abstract]   [Full Text] [Related]  

  • 19. Observation of the protective effect of live measles vaccines in the first year after vaccination.
    Sejda J; Helcl J; Strauss J
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(3):288-95. PubMed ID: 4161911
    [No Abstract]   [Full Text] [Related]  

  • 20. STUDIES ON KILLED AND ATTENUATED MEASLES VACCINES IN GENERAL PRACTICE.
    WATSON GI
    Br Med J; 1965 Jul; 2(5452):13-6. PubMed ID: 14305344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.